◀ Back to RHOA
RHOA — RICTOR
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Goncharova et al., Mol Cell Biol 2011
:
Our data demonstrate that
mTORC2 dependent activation of
RhoA is required for TSC2-null cell growth and survival and suggest that targeting both mTORC2 and mTORC1 by a combination of proapoptotic simvastatin and cytostatic rapamycin shows promise for combinational therapeutic intervention in diseases with TSC2 dysfunction
Back et al., Photochem Photobiol 2012
(Carcinoma, Squamous Cell...) :
Exogenous overexpression of
Rictor restores
RhoA-GTPase activity and actin cytoskeleton network, and decreases resveratrol induced senescence associated ß-gal activity, indicating a direct role of Rictor in senescence induction